Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Monster Beverage Corp (MNST) vs UnitedHealth Group Inc (UNH) Price & Performance

Monster Beverage CorpTrade
UnitedHealth Group IncTrade

Price performance (Past 24H)

Key statistics

Monster Beverage Corp vs UnitedHealth Group Inc — how do they compare? Monster Beverage Corp trades at $46.06 (market cap $89.20B), while UnitedHealth Group Inc trades at $405.33 (market cap $361.00B). The key difference: UnitedHealth Group Inc is far larger — about 4× Monster Beverage Corp's market cap, and UnitedHealth Group Inc pays a 2.31% dividend while Monster Beverage Corp pays none. Which is the better fit depends on your goals.

MNSTUNH
Market Cap
$89.20B$361.00B
Sector
Consumer StaplesHealth
52-Week High
$49.97$436.35
52-Week Low
$30.86$259.02
Enterprise Value
$87.49B$402.86B
Dividend Yield
2.31%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Monster Beverage Corp

Monster Beverage (MNST) trades at $45.895, up 0.45% with a bearish technical signal despite recent earnings beats. The company shows strong fundamentals with 2025 revenue of $8.29B and net income of $1.91B, achieving a 23.08% net margin. Recent Q2 2026 results beat expectations with $0.60 EPS versus $0.59 expected, driven by international growth. A 2-for-1 stock split occurred on August 11, 2026, while analyst consensus remains positive with 51% buy ratings and a $51.14 price target.

MNST's outlook is supported by robust earnings growth and global expansion, but elevated valuation ratios (P/E 42.16, P/S 9.75) pose risks. Competitive pressures in the energy drink sector and macroeconomic sensitivity could challenge margins. Institutional sentiment is cautiously optimistic, with upside potential to the consensus target representing 11% gain from current levels.

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $408.74, showing modest daily gains of 0.41% amid a bearish technical signal. The company demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust analyst support (82.7% buy ratings). Recent developments include dividend payments and strategic initiatives to streamline pediatric care authorizations, positioning UNH well in the healthcare sector.

UNH presents a compelling investment case with strong cash flow generation and market leadership, though investors face risks from regulatory scrutiny and margin compression. The stock trades at a discount to analyst consensus target of $476.50, offering potential upside if operational improvements and growth initiatives materialize as projected.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Monster Beverage Corp

Monster Beverage is a leader in the energy drink subsegment of the beverage industry. The Monster trademark anchors the portfolio, and notable offerings include Monster Energy and Monster Ultra. The firm has also started to incubate new trademarks for emerging enclaves of the energy space, like Reign in performance energy. It is primarily a brand owner, outsourcing most of its manufacturing processes to third-party copackers. It primarily uses the Coca-Cola bottling system for distribution after a strategic agreement in which Coke became Monster's largest shareholder (nearly 20%) and that also included the exchange of certain businesses between the two firms. Most of Monster's revenue is generated in the United States, though international geographies are increasing in the mix.

Read more on MNST

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH